What antibiotics are recommended for an otherwise healthy adult with an uncomplicated bacterial skin infection, and how should treatment be adjusted if methicillin‑resistant Staphylococcus aureus (MRSA) is suspected or if the patient has a beta‑lactam allergy?

Antibiotic Treatment for Uncomplicated Bacterial Skin Infections

For uncomplicated skin infections in healthy adults, use cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily for non-purulent infections; for purulent infections (abscesses) where MRSA is suspected, use trimethoprim-sulfamethoxazole (1-2 double-strength tablets twice daily) or clindamycin (300-400 mg four times daily) in conjunction with incision and drainage. 1

Treatment Algorithm Based on Infection Type

Non-Purulent Infections (Cellulitis, Erysipelas)

For simple cellulitis without systemic signs:

• First-line (MSSA coverage): Cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily 1
• Duration: 5 days for mild infections 2
• These infections are typically caused by methicillin-sensitive Staphylococcus aureus (MSSA) and Streptococcus pyogenes 1, 3

Purulent Infections (Abscesses, Carbuncles)

Critical point: Community-acquired MRSA now predominates in abscess infections in the United States, fundamentally changing treatment approach 3, 4

Primary treatment is incision and drainage, which may be sufficient alone for small abscesses in healthy patients 4. However, adding antibiotics improves outcomes:

• Clindamycin 300-400 mg four times daily OR
• Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily 1

The evidence strongly supports antibiotic use: A high-quality placebo-controlled trial demonstrated that both clindamycin (83.1% cure rate) and TMP-SMX (81.7% cure rate) significantly outperformed incision and drainage alone (68.9% cure rate, p<0.001) for abscesses ≤5 cm 5. Clindamycin showed an additional advantage with lower recurrence rates at 1 month (6.8% vs 13.5% for TMP-SMX, p=0.03) 5.

Beta-Lactam Allergy Considerations

For patients with beta-lactam allergies:

• Non-immediate hypersensitivity: Cephalosporins (cephalexin, cefazolin) can be used safely 1
• Immediate hypersensitivity (anaphylaxis): Avoid all beta-lactams
  • Use clindamycin 300-400 mg four times daily for both MSSA and MRSA coverage 1
  • Alternative: Doxycycline or minocycline 100 mg twice daily 1
  • For MSSA specifically: Trimethoprim-sulfamethoxazole is an option, though efficacy is less well-documented 1

MRSA-Specific Considerations

When to Suspect MRSA

Empiric MRSA coverage is warranted when:

• Purulent infections (abscesses) are present 3, 4
• Patient has failed initial beta-lactam therapy 1
• Systemic signs (fever, tachycardia, hypotension) are present 1
• Local epidemiology shows high MRSA prevalence 4

Oral MRSA-Active Agents (in order of preference based on evidence)

1. Clindamycin 300-400 mg four times daily - Bacteriostatic but effective 1, 5

   • Caveat: 10% resistance rate reported in some communities by 2012 6; check local susceptibility patterns
   • Risk of inducible resistance in erythromycin-resistant strains 1

2. Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily - Bactericidal 1, 5

   • Resistance increasing (6% in some areas by 2012) 6
   • Less gastrointestinal side effects than clindamycin 5

3. Doxycycline or minocycline 100 mg twice daily - Bacteriostatic 1

   • Not recommended for children <8 years 1

4. Linezolid 600 mg twice daily - Most effective but expensive 1, 7

   • Network meta-analysis shows superior clinical success rates compared to vancomycin (RR 1.71,95% CI 1.45-2.02) 7
   • Higher adverse event rate (21.9%) 5
   • Reserve for treatment failures or severe infections

Common Pitfalls to Avoid

1. Bilateral cellulitis is rare - Consider alternative diagnoses like venous stasis dermatitis or deep venous thrombosis 2

2. Don't assume all skin infections need MRSA coverage - Non-purulent cellulitis in healthy patients without risk factors can be treated with beta-lactams 1, 2

3. Resistance patterns are dynamic - MRSA resistance to clindamycin and TMP-SMX is increasing; local antibiograms should guide therapy 6

4. Culture when possible - For purulent lesions, obtain cultures to document MRSA and guide therapy, especially for treatment failures 4

5. Don't forget drainage - For abscesses, incision and drainage is essential; antibiotics alone are insufficient 4, 5

Severe Infections Requiring Hospitalization

If systemic inflammatory response syndrome (SIRS) is present (fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24 breaths/min, WBC >12,000 or <4,000 cells/μL):

• Vancomycin 30 mg/kg/day in 2 divided doses IV remains the parenteral drug of choice for MRSA 1, 4
• Alternatives: Linezolid 600 mg IV every 12 hours, daptomycin 4 mg/kg IV daily, or ceftaroline 600 mg IV twice daily 1
• For MSSA: Nafcillin or oxacillin 1-2 g IV every 4 hours 1